Skip to content
Trending storyDeveloping

Orexin Receptor 2 Agonists Succeed in Phase 3 Trials for Narcolepsy Type 1

1 report1 sourceupdated 3 hours ago

Start here

Synthesis

Narcolepsy type 1 is defined by cataplexy and a deficiency of orexin, a wakefulness-regulating neuropeptide, and is mostly autoimmune in origin, with more than 90% of patients carrying specific HLA variants. In type 2, orexin levels are normal and the mechanism is unknown. Diagnosis rests on sleep history plus a multiple sleep latency test showing mean sleep onset under 8 minutes with at least two REM onsets, and sometimes CSF orexin measurement. Orexin receptor 2 agonists, the first drug class to target the underlying neurochemical defect, significantly improved wakefulness and cataplexy in two phase 3 trials. The work underpinning the class was recognized when the 2026 Lasker Award went to orexin discoverers Mignot and Yanagisawa. Open questions include regulatory timelines and applicability to type 2 disease.

Written by a model from the reports · updated 2 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 10
  1. youtube.com
    Orexin Receptor 2 Agonists Succeed in Phase 3 for Narcolepsy Type 1

    A JAMA Network review discussion covers narcolepsy type 1, defined by cataplexy and orexin deficiency, mostly autoimmune in origin, with more than 90% of patients carrying specific HLA variants, versus type 2, where orexin is normal and the mechanism is unknown. Diagnosis rests on sleep history plus a multiple sleep latency test showing mean sleep onset under 8 minutes with at least two REM onsets, and sometimes CSF orexin measurement. Orexin receptor 2 agonists, the first drug class targeting the underlying neurochemical defect, significantly improved wakefulness and cataplexy in two phase 3 trials, and the 2026 Lasker Award went to orexin discoverers Mignot and Yanagisawa.

Heat trend for this story

Heat now 9·Peak in the comparable set 10 (Oct 18 04:00)·Change over 24h in the comparable set –

02.557.510Oct18Oct18Oct18Oct18

The trend compares only the participants observed in full throughout, so its set can be smaller than the heat figure itself. Move the pointer or click the chart for an hour's heat; the left and right arrow keys work too.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org